| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/19/2001 | WO2001051054A2 Use of cyclopentenone derivatives for bone and periodontal regeneration |
| 07/19/2001 | WO2001051053A1 Prostaglandin compositions and methods of treatment for male erectile dysfunction |
| 07/19/2001 | WO2001051052A1 Pharmaceutical preparation containing specific pde v inhibitors |
| 07/19/2001 | WO2001051050A1 Novel substituted benzimidazole dosage forms and method of using same |
| 07/19/2001 | WO2001051047A1 Use of fumaric acid derivatives for treating mitochondrial diseases |
| 07/19/2001 | WO2001051046A1 Airway alkalinization as therapy for airway diseases |
| 07/19/2001 | WO2001051041A1 Osmotic device containing venlafaxine and an anti-psychotic agent |
| 07/19/2001 | WO2001051040A1 Osmotic device containing alprazolam and an antipsychotic agent |
| 07/19/2001 | WO2001051039A1 Osmotic device containing ranitidine and a prokinetic agent |
| 07/19/2001 | WO2001051038A1 Osmotic device containing pseudoephedrine and an h1 antagonist |
| 07/19/2001 | WO2001051037A1 Osmotic device containing diltiazem and an ace inhibitor or diuretic |
| 07/19/2001 | WO2001051036A1 Osmotic device within an osmotic device |
| 07/19/2001 | WO2001051035A1 Combined diffusion/osmotic pumping drug delivery system |
| 07/19/2001 | WO2001051034A1 Ingestible or swallowable article made of fibrillar material |
| 07/19/2001 | WO2001051033A1 Solid pharmaceutical compositions for controlled release of active substances |
| 07/19/2001 | WO2001051032A2 Micronized freeze-dried particles |
| 07/19/2001 | WO2001051031A2 Enteric coated pharmaceutical formulation |
| 07/19/2001 | WO2001051030A1 Pharmaceutical formulation and method for pulmonary and oral delivery |
| 07/19/2001 | WO2001051029A1 Itraconazole composition and production method |
| 07/19/2001 | WO2001051027A2 Polymer blends as biodegradable matrices for preparing biocomposites |
| 07/19/2001 | WO2001051026A2 Instant granules and process for their formulation |
| 07/19/2001 | WO2001051025A2 Formulations of active components in the form of a solid dispersion |
| 07/19/2001 | WO2001051024A2 Implantation kit comprising a support phase and a solvent |
| 07/19/2001 | WO2001051014A1 Pharmaceutical and cosmetic carrier or composition for topical application |
| 07/19/2001 | WO2001051010A1 Dermatological suspensions (micro-matrix) |
| 07/19/2001 | WO2001051008A2 Selective activation of a th1 or th2 lymphocyte regulated immune response |
| 07/19/2001 | WO2001050994A1 Topical medicated bioadhesive compositions and methods of use and preparation thereof |
| 07/19/2001 | WO2001050983A1 Implantable device |
| 07/19/2001 | WO2001050873A1 Thickened oil compositions of edible oil |
| 07/19/2001 | WO2001050872A2 Method for produce sanitation using bacteriophages |
| 07/19/2001 | WO2001050866A2 Method and device for sanitation using bacteriophages |
| 07/19/2001 | WO2001022943A8 A slow release pharmaceutical composition comprising a magnesium oxychloride cement |
| 07/19/2001 | WO2001005481A3 Method and apparatus for the recovery of non-solvent type fills from gelatin capsules |
| 07/19/2001 | WO2001005361A3 Emulsifier-free finely dispersed systems of the oil-in-water type |
| 07/19/2001 | WO2001004271A3 Respiratory syncytial viruses expressing immune modulatory molecules |
| 07/19/2001 | WO2001001998A3 Treatment of endometriosis with antileukoprotease |
| 07/19/2001 | WO2000018378A9 Sustained release hydromorphone formulations exhibiting bimodal characteristics |
| 07/19/2001 | WO1999060869A8 Sitostanol formulation with emulsifier to reduce cholesterol absorption |
| 07/19/2001 | US20010008900 Administration of pharmaceuticals |
| 07/19/2001 | US20010008896 Treatment ofsexual disorders |
| 07/19/2001 | US20010008889 Anticonvulsant containing composition for treating neuropathic pain |
| 07/19/2001 | US20010008888 Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-O-(2-hydroxyethyl)-rapamycin |
| 07/19/2001 | US20010008885 Administering phosphocholine compound; leishmaniasis treatment |
| 07/19/2001 | US20010008880 Thrombolytic agents and methods of treatment for thrombosis |
| 07/19/2001 | US20010008772 Lipid, nucleic acid complex |
| 07/19/2001 | US20010008758 Electrosensitizing red blood cell; applying sound waves |
| 07/19/2001 | US20010008640 Bilayer structure which encapsulates multiple containment units and uses thereof |
| 07/19/2001 | US20010008639 Reducing dosage; analgesics |
| 07/19/2001 | US20010008638 Nutritional supplement comprising at least one prohormone and at least one anti-estrogen compound in a time-release dosage form |
| 07/19/2001 | US20010008637 Water insolubility hydrophobic synthetic material |
| 07/19/2001 | US20010008632 Aqueous medicament preparations for the production of propellent gas-free aerosols |
| 07/19/2001 | DE19954245A1 Mehrschichtige filmförmige Zubereitung aus hydrophilen Polymeren zur schnellen Freisetzung von Wirkstoffen Multilayer film-form preparation of hydrophilic polymers for rapid release of active ingredients |
| 07/19/2001 | DE10001546A1 Verfahren zur kontinuierlichen Herstellung und Beschichtung von Selbstlebemassen auf Basis von Polyisobutylen mit mindestens einem pharmazeutischen Wirkstoff A process for the continuous production and coating of self catering compositions based on polyisobutylene with at least one pharmaceutical active substance |
| 07/19/2001 | DE10001021A1 Pharmazeutische Zubereitung Pharmaceutical composition |
| 07/19/2001 | DE10000792A1 Formulierungen von Wirkstoffen in Form einer festen Dispersion Formulations of active ingredients in the form of a solid dispersion |
| 07/19/2001 | DE10000612A1 Aqueous active substance preparations, especially eye drops, nasal drops and nasal sprays, contain sodium chloride in place of preservatives |
| 07/19/2001 | DE10000333A1 Pharmazeutische Zusammensetzung zur transdermalen Verabreichung von Hormonen mit einem permeationsverbessernden Zusatzstoff A pharmaceutical composition for transdermal delivery of hormones with an additive permeationsverbessernden |
| 07/19/2001 | CA2430501A1 Method for produce sanitation using bacteriophages |
| 07/19/2001 | CA2430500A1 Method and device for sanitation using bacteriophages |
| 07/19/2001 | CA2430498A1 Reduction in bacterial colonization by administering bacteriophage compositions |
| 07/19/2001 | CA2397068A1 Pharmaceutical and cosmetic carrier or composition for topical application |
| 07/19/2001 | CA2397053A1 Human and parasite orphan receptor proteins |
| 07/19/2001 | CA2396237A1 Selective activation of a th1 or th2 lymphocyte regulated immune response |
| 07/19/2001 | CA2396214A1 Osmotic device containing alprazolam and an antipsychotic agent |
| 07/19/2001 | CA2396071A1 Thickened oil compositions of edible oil |
| 07/19/2001 | CA2395567A1 Novel treatment for eye disease |
| 07/19/2001 | CA2394831A1 Monocyte-derived dendritic cell subsets |
| 07/19/2001 | CA2366411A1 Topical medicated bioadhesive compositions and methods of use and preparation thereof |
| 07/18/2001 | EP1116763A2 Process for the continuous production and coating of self-adhesive masses based on polyisobutylene and at least one pharmaceutical active compound |
| 07/18/2001 | EP1116733A1 Water-soluble or water-swellable crosslinked copolymers |
| 07/18/2001 | EP1116516A1 Templating of solid particles by polymer multilayers |
| 07/18/2001 | EP1116515A2 Encapsulated liquid |
| 07/18/2001 | EP1116489A1 Oral drug delivery system for enhancing the bioavailability of activated glycyrrhetin |
| 07/18/2001 | EP1116485A2 Instant granulate and process for its preparation |
| 07/18/2001 | EP1116483A1 Oil-in-water emulsion composition |
| 07/18/2001 | EP1115818A1 Water-soluble concentrate obtained for an emulgator or water-solubilising phase and a complex of liquid lipophile substances of plant origin |
| 07/18/2001 | EP1115748A1 Carrageenan compositions, and processes for their production |
| 07/18/2001 | EP1115747A1 Polymer complexes of glucuronoglucanes |
| 07/18/2001 | EP1115480A2 Microparticles produced from cyclic olefin copolymers and their use for the controlled release of active agents |
| 07/18/2001 | EP1115478A2 Emollient esters based upon capryl alcohol and isostearic acid |
| 07/18/2001 | EP1115454A1 Controlled dosage drug delivery system |
| 07/18/2001 | EP1115452A1 Systems and methods for treating ischemia |
| 07/18/2001 | EP1115433A1 Functionalized derivatives of hyaluronic acid, formation of hydrogels and in situ using same |
| 07/18/2001 | EP1115411A1 Extract of nerium species, pharmaceutical composition thereof and methods for preparation thereof |
| 07/18/2001 | EP1115409A1 Composition for extending post meal satiety |
| 07/18/2001 | EP1115406A2 Sustained release, and comfortable ophthalmic composition and method for ocular therapy |
| 07/18/2001 | EP1115391A1 Chemotherapy of cancer with acetyldinaline in combination with gemcitabine, capecitabine or cisplatin |
| 07/18/2001 | EP1115385A1 Prevention and treatment of parodontitis |
| 07/18/2001 | EP1115384A1 Fentanyl composition for the treatment of acute pain |
| 07/18/2001 | EP1115383A1 Pharmaceutical composition for the treatment of acute disorders |
| 07/18/2001 | EP1115382A2 Immunogenic liposome compositions |
| 07/18/2001 | EP1115381A1 Proteinic drug delivery system using membrane mimetics |
| 07/18/2001 | EP1115380A2 Micronised pharmaceutical compositions |
| 07/18/2001 | EP1115379A2 Liquid pharmaceutical for oral delivery |
| 07/18/2001 | EP1115378A1 Oral mucoadhesive compositions containing gastrointestinal actives |
| 07/18/2001 | EP1115377A1 Semi-moist oral delivery system |
| 07/18/2001 | EP1115375A1 Use of at least a10-hydroxy-2- decenoic acid derivative in a composition for promoting skin scaling |
| 07/18/2001 | EP1115373A1 Oral composition with an improved teeth whitening effect |
| 07/18/2001 | EP1115372A2 Fast dissolving orally consumable films |
| 07/18/2001 | EP1115371A1 Oral care compositions |